News und Analysen
Pfizer Announces Positive Top-Line Results from Phase 3 Study of Hemophilia B Gene Therapy Candidate
Pfizer Inc. (NYSE: PFE) today announced positive top-line results from the Phase 3 BENEGENE-2 study (NCT03861273) evaluating fidanacogene elaparvovec, an investigational gene therapy, for the
T-Mobile US, Inc. to Present at Citi’s 2023 Communications, Media & Entertainment Conference
Peter Osvaldik, executive vice president & chief financial officer of T-Mobile US, Inc. (NASDAQ: TMUS), will present and provide a business update on Wednesday, January 4, 2023 at 4:15 p.m
QuidelOrtho to Present at the J.P. Morgan Healthcare Conference
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion
U.S. FDA Accepts for Review the Biologics License Application for Pfizer’s Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents
Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for review a Biologics License Application (BLA) for its investigational pentavalent meningococcal
Exelon Announces Extension of Exchange Offers
Exelon Corporation (Exelon) (Nasdaq: EXC) today announced that it has extended the expiration date for each of its offers to exchange any and all of its outstanding unregistered notes listed below
Carmax Reports Third Quarter Fiscal 2023 Results
CarMax, Inc. (NYSE:KMX) today reported results for the third quarter ended November 30, 2022.
Highlights:
-
Net revenues of $6.5 billion, down 23.7% compared with the prior year third quarter
State Street Corporation Announces Date for Release of Fourth-Quarter and Full-Year 2022 Financial Results and Conference Call Webcast
State Street Corporation (NYSE: STT) plans to announce its fourth-quarter and full-year 2022 financial results on Friday, January 20, 2023 at approximately 7:30 a.m. ET. The results will be
Hope Mehlman Joins Discover as Chief Legal Officer and General Counsel
Hope Mehlman, an accomplished leader, business executive and legal expert with over 20 years of legal, compliance, regulatory, and risk management experience in the financial services industry and
Freeport-McMoRan Declares Quarterly Cash Dividends on Common Stock
Freeport-McMoRan Inc. (NYSE: FCX) announced today that its Board of Directors declared cash dividends of $0.15 per share on FCX’s common stock payable on February 1, 2023, to shareholders of record
Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for etrasimod for individuals living with
NIKE, Inc. Reports Fiscal 2023 Second Quarter Results
NIKE, Inc. (NYSE:NKE) today reported fiscal 2023 financial results for its second quarter ended November 30, 2022.
-
Second quarter reported revenues were $13.3 billion, up 17 percent compared to
Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, January 31, 2023. The
FICO UK Credit Card Market Report: October 2022
FICO’s latest report of UK card trends — for October 2022 — illustrates the push and pull of personal finances as consumers attempt to manage existing credit commitments while facing an increased
IFF Announces the Sale of Its Savory Solutions Group to PAI Partners
IFF (NYSE: IFF) today announced it has entered into an agreement to sell its Savory Solutions Group to PAI Partners, a leading global private equity firm with a strong focus on the food and
Xylem Appoints Matthew Pine Chief Operating Officer
Global water technology company Xylem Inc. (NYSE: XYL), today announced the appointment of Matthew Pine as Chief Operating Officer, effective January 1, 2023. In this role, Pine will accelerate
Health Canada Grants License for Quidel® TriageTrue® High-Sensitivity Troponin I Test to Aid in the Diagnosis of Myocardial Infarction
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine
Exelon receives national recognition for leadership and excellence in workforce development
For the second consecutive year, Exelon (Nasdaq: EXC) was selected by the Center for Energy Workforce Development (CEWD) to receive its highest honor, the Chairman’s Award, which recognizes a
Eggplant Recognized as a Leader Among Continuous Test Automation Providers
Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that delivers advanced design and validation solutions to help accelerate innovation to connect and secure the world
Keysight Delivers First 3GPP Release 16 Dual Connectivity Protocol Test Case Verifications for 5G New Radio Non-Standalone Devices
Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that delivers advanced design and validation solutions to help accelerate innovation to connect and secure the world
Altria Abandons Expiring Cronos Warrant; Maintains Initial Investment
Altria Group, Inc (NYSE:MO) today announced that its wholly owned subsidiary, Altria Summit LLC, has notified Cronos Group Inc. (Cronos) of its irrevocable abandonment of (i) its warrant to
Waters Corporation Named to Dow Jones Sustainability Index for Second Consecutive Year
Waters Corporation (NYSE:WAT) announced it has been named to the Dow Jones Sustainability North America Index (DJSI North America) for the second consecutive year. The DJSI is informed by the S&P
IFF Names Sabrya Meflah President, Fine Fragrance
IFF (NYSE: IFF) has named Sabrya Meflah President of its Fine Fragrance business unit, effective immediately. Meflah—who is currently vice president and regional general manager, Europe, Middle
ServiceNow Reports New Hire Equity Grants
ServiceNow (NYSE: NOW), the leading digital workflow company making the world work better for everyone, today announced that on Dec. 15, 2022, its Compensation Committee granted equity awards
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
Agilent Technologies Inc. (NYSE: A) today announced that CEO Mike McMullen and CFO Bob McMahon will present at the Goldman Sachs Healthcare CEOs Unscripted Conference and the J.P. Morgan Healthcare
QuidelOrtho and Runda Medical Form Joint Venture to Develop and Manufacture Assays for VITROS® Platform
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho” or the “Company”), a global provider of innovative in vitro diagnostics (IVD) technologies designed for point-of-care settings, clinical labs